Phase I Pilot Study to Evaluate the Anti-glioblastoma Effect of S-Gboxin in Standard Treatment of Glioblastoma/Diffuse Midline Glioma and Response to Treatment (Regardless of Mutation Status)

NCT06806228 · clinicaltrials.gov ↗

PHASE1

Phase

SUSPENDED

Status

10

Enrollment

OTHER

Sponsor class

Stopped The study protocol will be changed

Conditions

Glioblastoma Multiforme
Diffuse Midline Glioma, H3 K27M-Mutant
Gliosarcoma
Giant Cell Glioblastoma
GBM

Interventions

BIOLOGICAL: S-Gboxin

Sponsor

Petrov, Andrey

Collaborators

Lytvin,Ruslan